Next report date
Report period
Q1 2024
EPS estimate
−1.41USD
Revenue estimate
—
−117.17 MUSD
3.60 MUSD
14.98 M
Om Adverum Biotechnologies, Inc.
Sektor
Bransch
VD
Laurent Fischer
Webbplats
Huvudkvarter
Redwood City
Employees (FY)
121
Grundat
2006
FIGI
BBG006D9MR17
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
